15.1 C
Delhi
Thursday, November 6, 2025

RBI vs SBI: Top Economist Levels Plagiarism Accusations

RBI Economist Accuses SBI of Plagiarism in LinkedIn Showdown

A senior RBI economist has publicly accused State Bank of India researchers of plagiarizing content from the central bank’s Monetary Policy Reports in their Ecowrap publications, sparking an unprecedented social media confrontation between India’s two premier financial institutions.

Key Takeaways

  • RBI’s Sarthak Gulati alleges SBI Ecowrap copied “paragraph by paragraph” from RBI reports
  • SBI research team denies all plagiarism charges
  • Economist Ajit Ranade calls for proper attribution standards

The Allegations

RBI Assistant General Manager Sarthak Gulati detailed the accusations in a LinkedIn post during Diwali festivities, claiming SBI’s research team had copied key data, graphs, and charts without attribution.

“As professionals in the financial and economic research community, we rely on originality, attribution, and integrity in our analysis. That’s why it’s deeply concerning to see what appears to be verbatim replication of RBI’s Monetary Policy Reports,” Gulati stated.

He specifically cited July 2025 Ecowrap replicating “large parts of Chapter 2: Price and Cost from the RBI’s April 2025 MPR—paragraph by paragraph” and October 2025 Ecowrap similarly mirroring language and structure from the corresponding RBI report.

SBI’s Response

One day after the allegations surfaced, SBI Research team member Dr. Tapas Parida rejected all charges in a detailed rebuttal.

“We have gone on to update the observations with latest data and duly acknowledged Central Bank as source in our tables,” Dr. Parida asserted, defending the team’s research integrity.

The SBI response concluded with a Rumi quote emphasizing the importance of raising words rather than voices, while reaffirming their commitment to ethical research standards.

Industry Reaction

Prominent economist Ajit Ranade weighed in on the controversy, stating:

“Stealing ideas may be flattering to the original author, but is a serious breach of the code among academics and researchers. Proper attribution, citation, and providing references are basics.”

The public dispute highlights growing concerns about research ethics and attribution standards within India’s financial research community.

Latest

Novo Nordisk Cuts Forecasts Again Amid Weight-Loss Drug Competition

Ozempic maker Novo Nordisk slashes financial guidance for the fourth time as competition from Eli Lilly and copycat drugs intensifies in the weight-loss market.

BoI and SET Partner to Boost Thailand Stock Market Listings

Thailand's investment applications surge 94% as BoI and SET collaborate to promote listings in smart electronics, EVs and digital sectors.

Britannia Q2 Profit Surges 23% to Rs 655 Crore, Beats Estimates

Britannia Industries reports strong Q2 results with 23% profit growth and expanded margins, while announcing new CEO appointment. Key financial highlights and outlook.

Novo Nordisk Q3 Profit Falls 27%, Cuts 9,000 Jobs Amid Restructuring

Ozempic maker Novo Nordisk reports declining profits, job cuts and lowered outlook amid increasing competition in obesity drug market.

Amul, IFFCO Secure Top Two Spots in Global Cooperative Rankings

India's Amul ranks #1 and IFFCO #2 in world cooperative rankings, recognizing millions of farmers' contributions and India's growing cooperative sector strength.

Topics

Scientists Demand Ban on Chelsea Tractors After Fatal Crash Data

Imperial College researchers reveal SUVs are 82% more deadly to children and demand urgent action to remove these dangerous vehicles from British cities.

India Cuts Russian Oil Imports After US Sanctions on Rosneft, Lukoil

Major Indian refiners halt direct Russian crude purchases from December as US sanctions take effect, shifting to alternative suppliers amid market changes.

India-US Trade Agreement Talks Progress Despite Sensitive Issues

Commerce Minister Piyush Goyal confirms continuous India-US trade talks with 2025 deadline. Five rounds completed for bilateral trade agreement.

Novo Nordisk Cuts Forecasts Again Amid Weight-Loss Drug Competition

Ozempic maker Novo Nordisk slashes financial guidance for the fourth time as competition from Eli Lilly and copycat drugs intensifies in the weight-loss market.

Particle Accelerator Reveals Perfect Pasta Cooking Method

Scientists used particle accelerators to discover the ideal salt level and cooking time for perfect pasta, explaining why gluten-free versions turn mushy.

BoI and SET Partner to Boost Thailand Stock Market Listings

Thailand's investment applications surge 94% as BoI and SET collaborate to promote listings in smart electronics, EVs and digital sectors.

Chinese Astronauts Stranded on Space Station After Debris Damage

Three astronauts face extended space stay as their return capsule may have been damaged by orbital debris. Joint inspection underway for safe return.

Britannia Q2 Profit Surges 23% to Rs 655 Crore, Beats Estimates

Britannia Industries reports strong Q2 results with 23% profit growth and expanded margins, while announcing new CEO appointment. Key financial highlights and outlook.
spot_img

Related Articles

Popular Categories

spot_imgspot_img